{
    "eid": "2-s2.0-85159655410",
    "title": "An international multidisciplinary consensus statement on MAFLD and the risk of CVD",
    "cover-date": "2023-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hepatology",
            "@code": "2721",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Cardiovascular disease",
        "Consensus",
        "Delphi survey",
        "MAFLD",
        "Metabolic (dysfunction)-associated fatty liver disease",
        "Non-alcoholic fatty liver disease"
    ],
    "authors": [
        "Xiao Dong Zhou",
        "Giovanni Targher",
        "Christopher D. Byrne",
        "Virend Somers",
        "Seung Up Kim",
        "C. Anwar A. Chahal",
        "Vincent Wai Sun Wong",
        "Jingjing Cai",
        "Michael D. Shapiro",
        "Mohammed Eslam",
        "Philippe Gabriel Steg",
        "Ki Chul Sung",
        "Anoop Misra",
        "Jian Jun Li",
        "Carlos Brotons",
        "Yuli Huang",
        "George V. Papatheodoridis",
        "Aijun Sun",
        "Yusuf Yilmaz",
        "Wah Kheong Chan",
        "Hui Huang",
        "Nahum M\u00e9ndez-S\u00e1nchez",
        "Saleh A. Alqahtani",
        "Helena Cortez-Pinto",
        "Gregory Y.H. Lip",
        "Robert J. de Knegt",
        "Ponsiano Ocama",
        "Manuel Romero-Gomez",
        "Marat Fudim",
        "Giada Sebastiani",
        "Jang Won Son",
        "John D. Ryan",
        "Ignatios Ikonomidis",
        "Sombat Treeprasertsuk",
        "Daniele Pastori",
        "Monica Lupsor-Platon",
        "Herbert Tilg",
        "Hasmik Ghazinyan",
        "Jerome Boursier",
        "Masahide Hamaguchi",
        "Mindie H. Nguyen",
        "Jian Gao Fan",
        "George Boon Bee Goh",
        "Mamun Al Mahtab",
        "Saeed Hamid",
        "Nilanka Perera",
        "Jacob George",
        "Ming Hua Zheng"
    ],
    "citedby-count": 4,
    "ref-count": 156,
    "ref-list": [
        "Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes",
        "The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases",
        "A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement",
        "Promoting the term MAFLD: China in action",
        "MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease",
        "From NAFLD to MAFLD: a \"redefining\" moment for fatty liver disease",
        "The NAFLD-MAFLD debate: eminence vs evidence",
        "Metabolic (dysfunction) associated fatty liver disease: more evidence and a bright future",
        "From NAFLD to MAFLD: when pathophysiology succeeds",
        "Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention",
        "Meaning of non-overlapping patients between the MAFLD and NAFLD definitions",
        "Impact of the new definition of metabolic associated fatty liver disease on the epidemiology of the disease",
        "MAFLD and risk of CKD",
        "Clinical utility of the MAFLD definition",
        "WHO urges immediate action to tackle non-communicable diseases",
        "Advancing the global public health agenda for NAFLD: a consensus statement",
        "Joint international consensus statement for ending stigma of obesity",
        "Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease",
        "NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications",
        "A meta-analysis on the global prevalence, risk factors and screening of coronary heart disease in nonalcoholic fatty liver disease",
        "Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: a systematic review and meta-analysis",
        "Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach",
        "Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis",
        "Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis: a systematic review and meta-analysis",
        "MAFLD predicts the risk of cardiovascular disease better than NAFLD in asymptomatic subjects with health check-ups",
        "NAFLD or MAFLD: which has closer association with all-cause and cause-specific mortality? Results from NHANES III",
        "MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach",
        "Cardiovascular and renal burdens among patients with MAFLD and NAFLD in China",
        "Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan",
        "Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: a nationwide cohort study",
        "Association of MAFLD With diabetes, chronic kidney disease, and cardiovascular disease: a 4.6-year cohort study in China",
        "Metabolic dysfunction-associated fatty liver disease and cardiovascular disease: a meta-analysis",
        "Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis",
        "Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis",
        "Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States",
        "Outcomes of NAFLD and MAFLD: results from a community-based, prospective cohort study",
        "Comparative effects of non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease on risk of incident cardiovascular events: a meta-analysis of about 13 million individuals",
        "Cardiovascular and renal burdens of metabolic associated fatty liver disease from serial US national surveys, 1999\u20132016",
        "Predicting coronary heart disease using risk factor categories for a japanese urban population, and comparison with the Framingham risk score: the suita study",
        "Assessment of hepatic fibrosis in MAFLD: A new player in the evaluation of residual cardiovascular risk?",
        "Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population",
        "Nonalcoholic fatty liver disease and fibrosis associated with increased risk of cardiovascular events in a prospective study",
        "Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease",
        "Fibrotic burden determines cardiovascular risk among subjects with metabolic dysfunction-associated fatty liver disease",
        "New insights into the pathogenesis of non-alcoholic fatty liver disease: gut-derived lipopolysaccharides and oxidative stress",
        "ADAPT: an algorithm incorporating PRO-C3 accurately identifies patients with NAFLD and advanced fibrosis",
        "Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease",
        "Association of hepatic steatosis with major adverse cardiovascular events, independent of coronary artery disease",
        "Associations of the fatty liver and hepatic steatosis indices with risk of cardiovascular disease: interrelationship with age",
        "Fatty liver index and development of cardiovascular disease: findings from the UK biobank",
        "The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study",
        "Metabolic dysfunction-associated fatty liver disease predicts long-term mortality and cardiovascular disease",
        "Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: an updated meta-analysis with 135,602 individuals",
        "A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclinical atherosclerosis",
        "New definition of metabolic dysfunction-associated fatty liver disease with elevated brachial-ankle pulse wave velocity and albuminuria: a prospective cohort study",
        "The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: a prospective analysis",
        "Comparative associations of nonalcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease with coronary artery calcification: a cross-sectional and longitudinal cohort study",
        "Metabolic-associated fatty liver disease and major adverse cardiac events in patients with chronic coronary syndrome: a matched case-control study",
        "The prevalence of metabolic dysfunction-associated fatty liver disease and its association with physical function and prognosis in patients with acute coronary syndrome",
        "Differential clinical characteristics and mortality outcomes in persons with NAFLD and/or MAFLD",
        "Relationship between non-alcoholic fatty liver disease and cardiac arrhythmia: a systematic review and meta-analysis",
        "The prevalence of MAFLD and its association with atrial fibrillation in a nationwide health check-up population in China",
        "High liver fibrosis scores in metabolic dysfunction-associated fatty liver disease patients are associated with adverse atrial remodeling and atrial fibrillation recurrence following catheter ablation",
        "Association between nonalcoholic fatty liver disease and cardiac function and structure-a meta-analysis",
        "Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysis",
        "Association of metabolic dysfunction-associated fatty liver disease with left ventricular diastolic function and cardiac morphology",
        "Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease",
        "Risk of heart failure in patients with nonalcoholic fatty liver disease: JACC review topic of the week",
        "Nonalcoholic fatty liver disease and the heart: JACC state-of-the-art review",
        "NAFLD and cardiovascular diseases: epidemiological, mechanistic and therapeutic considerations",
        "Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile",
        "Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications",
        "Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk",
        "Pathophysiological molecular mechanisms of obesity: a link between MAFLD and NASH with cardiovascular diseases",
        "Association between insulin resistance and the development of cardiovascular disease",
        "Renin-angiotensin system and fibrosis in non-alcoholic fatty liver disease",
        "Nonalcoholic fatty liver disease and the renin-angiotensin system: implications for treatment",
        "Chrysin attenuates fructose-induced nonalcoholic fatty liver in rats via antioxidant and anti-inflammatory effects: the role of angiotensin-converting enzyme 2/angiotensin (1\u20137)/mas receptor axis",
        "Angiotensin-converting enzyme inhibitors prevent liver-related events in nonalcoholic fatty liver disease",
        "Treatments for NAFLD: state of art",
        "The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases",
        "The genetics of nonalcoholic fatty liver disease: spotlight on PNPLA3 and TM6SF2",
        "Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease",
        "PNPLA3, TM6SF2, and MBOAT7 genotypes and coronary artery disease",
        "Patatin-like phospholipase domain containing 3 variants differentially impact metabolic traits in individuals at high risk for cardiovascular events",
        "Exome-wide association study of plasma lipids in >300,000 individuals",
        "Coronary artery disease genetics enlightened by genome-wide association studies",
        "Nonalcoholic fatty liver disease pandemic fuels the upsurge in cardiovascular diseases",
        "Metabolic-associated fatty liver disease (MAFLD), diabetes, and cardiovascular disease: associations with fructose metabolism and gut microbiota",
        "Intestinal microbiota in cardiovascular health and disease: JACC state-of-the-art review",
        "The gut microbiota as an influencing factor of arterial thrombosis",
        "The gut-liver axis in liver disease: Pathophysiological basis for therapy",
        "Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and meta-analysis",
        "Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders",
        "Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives",
        "Gut microbiota and cardiovascular disease",
        "European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO)",
        "Screening of cardiovascular disease in nonalcoholic fatty liver disease: whom and how?",
        "Nonalcoholic fatty liver disease: an emerging modern-day risk factor for cardiovascular disease",
        "Diagnostic accuracy of carotid intima media thickness by B-mode ultrasonography in coronary artery disease patients",
        "Common carotid intima-media thickness does not add to Framingham risk score in individuals with diabetes mellitus: the USE-IMT initiative",
        "Apolipoproteins and liver parameters optimize cardiovascular disease risk-stratification in nonalcoholic fatty liver disease",
        "Screening for nonalcoholic fatty liver disease in the primary care clinic",
        "Reply to: \"Assessment of hepatic fibrosis in MAFLD: a new player in the evaluation of residual cardiovascular risk?\"",
        "Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease",
        "Challenges and opportunities in NASH drug development",
        "Outcomes and potential surrogate markers for future clinical trials of non-alcoholic steatohepatitis cirrhosis",
        "Lifestyle interventions for non-obese patients both with, and at risk, of non-alcoholic fatty liver disease",
        "Lifestyle interventions for patients with nonalcoholic fatty liver disease: a network meta-analysis",
        "The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease",
        "Management of non-alcoholic fatty liver disease",
        "Adherence to mediterranean diet and non-alcoholic fatty liver disease: effect on insulin resistance",
        "Poor adherence to Mediterranean Diet and serum lipopolysaccharide are associated with oxidative stress in patients with non-alcoholic fatty liver disease",
        "The role of physical activity in nonalcoholic and metabolic dysfunction associated fatty liver disease",
        "Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review",
        "Nonheavy drinking and worsening of noninvasive fibrosis markers in nonalcoholic fatty liver disease: a cohort study",
        "Nonheavy alcohol use associates with liver fibrosis and nonalcoholic steatohepatitis in the Framingham heart study",
        "Among patients with nonalcoholic fatty liver disease, modest alcohol use is associated with less improvement in histologic steatosis and steatohepatitis",
        "Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis",
        "Alcohol consumption and mortality in patients with cardiovascular disease: a meta-analysis",
        "Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies",
        "Relationship between alcohol intake, health and social status and cardiovascular risk factors in the Urban Paris-Ile-de-France Cohort: is the cardioprotective action of alcohol a myth?",
        "Cardiovascular risk factors and confounders among nondrinking and moderate-drinking US adults",
        "Association of habitual alcohol intake with risk of cardiovascular disease",
        "Alcohol use and cardiovascular disease risk in patients with nonalcoholic fatty liver disease",
        "Moderate alcohol consumption is not associated with subclinical cardiovascular damage but with hepatic fibrosis in non-alcoholic fatty liver disease",
        "SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease",
        "Liraglutide, sitagliptin, and insulin glargine added to metformin: the effect on body weight and intrahepatic lipid in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease",
        "Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials",
        "Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis",
        "Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study",
        "A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis",
        "Glucagon-like peptide-1 receptor agonists for treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: an updated meta-analysis of randomized controlled trials",
        "Sodium-glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus",
        "Clinical benefit of cardiorenal effects of sodium-glucose cotransporter 2 inhibitors: JACC state-of-the-art review",
        "Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus",
        "Mechanisms of cardiorenal effects of sodium-glucose cotransporter 2 inhibitors: JACC state-of-the-art review",
        "Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin",
        "Empagliflozin for the treatment of nonalcoholic steatohepatitis in patients with type 2 diabetes mellitus",
        "Sodium-glucose cotransporter-2 inhibitors for treatment of nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials",
        "A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis",
        "Cardiac outcomes after ischemic stroke or transient ischemic attack: effects of pioglitazone in patients with insulin resistance without diabetes mellitus",
        "Heart failure after ischemic stroke or transient ischemic attack in insulin-resistant patients without diabetes mellitus treated with pioglitazone",
        "Pioglitazone use and risk of bladder cancer: a systematic literature review and meta-analysis of observational studies",
        "Effect of pioglitazone on bone mineral density in patients with nonalcoholic steatohepatitis: a 36-month clinical trial",
        "Deuterium-stabilized (R)-pioglitazone (PXL065) Is responsible for pioglitazone efficacy in NASH yet exhibits little to no PPAR\u03b3 activity",
        "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines",
        "Statin liver safety in non-alcoholic fatty liver disease: a systematic review and metanalysis",
        "Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis",
        "Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: a systematic review and meta-analysis",
        "Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease",
        "Effects of pentoxifylline on nonalcoholic fatty liver disease: a meta-analysis",
        "Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis",
        "Benefits and risks of bariatric surgery in adults: a review",
        "Association of bariatric surgery with major adverse liver and cardiovascular outcomes in patients with biopsy-proven nonalcoholic steatohepatitis",
        "Association of bariatric surgery with cardiovascular outcomes in adults with severe obesity and nonalcoholic fatty liver disease"
    ],
    "affiliation": [
        {
            "affiliation-city": "Wenzhou",
            "@id": "60122342",
            "affilname": "The First Affiliated Hospital of Wenzhou Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60122342",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Stanford",
            "@id": "60015615",
            "affilname": "Stanford Healthcare",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015615",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Kyoto",
            "@id": "60171739",
            "affilname": "Graduate School of Medical Science",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60171739",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Paris",
            "@id": "60123796",
            "affilname": "Universit\u00e9 Paris Cit\u00e9",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60123796",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Shenzhen",
            "@id": "60122353",
            "affilname": "The Eighth Affiliated Hospital, Sun Yat-sen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60122353",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Barcelona",
            "@id": "60102742",
            "affilname": "Sardenya Primary Health Care Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60102742",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Nugegoda",
            "@id": "60097294",
            "affilname": "University of Sri Jayewardenepura",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60097294",
            "affiliation-country": "Sri Lanka"
        },
        {
            "affiliation-city": "Montreal",
            "@id": "60085312",
            "affilname": "McGill University Health Centre, Royal Victoria Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60085312",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "New Delhi",
            "@id": "60081403",
            "affilname": "Diabetes Foundation (India), New Delhi",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60081403",
            "affiliation-country": "India"
        },
        {
            "affiliation-city": "Rize",
            "@id": "60079638",
            "affilname": "Recep Tayyip Erdogan University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60079638",
            "affiliation-country": "Turkey"
        },
        {
            "affiliation-city": "Shanghai",
            "@id": "60073654",
            "affilname": "Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073654",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Kampala",
            "@id": "60071678",
            "affilname": "School of Medicine, Makerere University College of Health Sciences",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071678",
            "affiliation-country": "Uganda"
        },
        {
            "affiliation-city": "Karachi",
            "@id": "60067302",
            "affilname": "The Aga Khan University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60067302",
            "affiliation-country": "Pakistan"
        },
        {
            "affiliation-city": "Athens",
            "@id": "60067083",
            "affilname": "School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60067083",
            "affiliation-country": "Greece"
        },
        {
            "affiliation-city": "Sevilla",
            "@id": "60033267",
            "affilname": "Hospital Universitario Virgen del Roc\u00edo",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60033267",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Mexico",
            "@id": "60032442",
            "affilname": "Universidad Nacional Aut\u00f3noma de M\u00e9xico",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032442",
            "affiliation-country": "Mexico"
        },
        {
            "affiliation-city": "Rome",
            "@id": "60032350",
            "affilname": "Sapienza Universit\u00e0 di Roma",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032350",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Rotterdam",
            "@id": "60032114",
            "affilname": "Erasmus MC",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032114",
            "affiliation-country": "Netherlands"
        },
        {
            "affiliation-city": "Winston Salem",
            "@id": "60031437",
            "affilname": "Wake Forest University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031437",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Durham",
            "@id": "60030982",
            "affilname": "Duke Clinical Research Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030982",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Kuala Lumpur",
            "@id": "60029157",
            "affilname": "Universiti Malaya",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029157",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Athens",
            "@id": "60028900",
            "affilname": "National and Kapodistrian University of Athens",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028900",
            "affiliation-country": "Greece"
        },
        {
            "affiliation-city": "Istanbul",
            "@id": "60027981",
            "affilname": "Marmara \u00dcniversitesi",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027981",
            "affiliation-country": "Turkey"
        },
        {
            "affiliation-city": "Beijing",
            "@id": "60026701",
            "affilname": "Fuwai Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026701",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Sydney",
            "@id": "60025709",
            "affilname": "The University of Sydney",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025709",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Aalborg",
            "@id": "60022134",
            "affilname": "Aalborg University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022134",
            "affiliation-country": "Denmark"
        },
        {
            "affiliation-city": "Southampton",
            "@id": "60021722",
            "affilname": "Southampton General Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021722",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Lisbon",
            "@id": "60021696",
            "affilname": "Faculdade de Medicina, Universidade de Lisboa",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021696",
            "affiliation-country": "Portugal"
        },
        {
            "affiliation-city": "Liverpool",
            "@id": "60020661",
            "affilname": "University of Liverpool",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020661",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "60017958",
            "affilname": "Singapore General Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017958",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Changsha",
            "@id": "60017060",
            "affilname": "Central South University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017060",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60016728",
            "affilname": "Yonsei University College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016728",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Riyadh",
            "@id": "60016332",
            "affilname": "King Faisal Specialist Hospital and Research Centre",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016332",
            "affiliation-country": "Saudi Arabia"
        },
        {
            "affiliation-city": "Suwon",
            "@id": "60016329",
            "affilname": "SKKU School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016329",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Cluj Napoca",
            "@id": "60013180",
            "affilname": "Universitatea de Medicina si Farmacie Iuliu Hatieganu din Cluj-Napoca",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013180",
            "affiliation-country": "Romania"
        },
        {
            "affiliation-city": "Shanghai",
            "@id": "60009860",
            "affilname": "Fudan University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009860",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Angers",
            "@id": "60009445",
            "affilname": "CHU Angers",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009445",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Innsbruck",
            "@id": "60008222",
            "affilname": "Medizinische Universitat Innsbruck",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008222",
            "affiliation-country": "Austria"
        },
        {
            "affiliation-city": "Wenzhou",
            "@id": "60008073",
            "affilname": "Wenzhou Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008073",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Dhaka",
            "@id": "60007825",
            "affilname": "Bangabandhu Sheikh Mujib Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007825",
            "affiliation-country": "Bangladesh"
        },
        {
            "affiliation-city": "Rochester",
            "@id": "60005558",
            "affilname": "Mayo Clinic",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Durham",
            "@id": "60005200",
            "affilname": "Duke University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005200",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "London",
            "@id": "60004093",
            "affilname": "St Bartholomew's Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004093",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Hong Kong",
            "@id": "60002798",
            "affilname": "Chinese University of Hong Kong",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002798",
            "affiliation-country": "Hong Kong"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Guangzhou",
            "@id": "60002593",
            "affilname": "Southern Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002593",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60001727",
            "affilname": "College of Medicine of the Catholic University of Korea",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60001727",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Baltimore",
            "@id": "60001117",
            "affilname": "Johns Hopkins School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60001117",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Verona",
            "@id": "60000799",
            "affilname": "Universit\u00e0 di Verona Scuola di Medicina e Chirurgia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000799",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Dublin",
            "@id": "60000718",
            "affilname": "Beaumont Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000718",
            "affiliation-country": "Ireland"
        },
        {
            "affiliation-city": "Wenzhou",
            "@id": "125564303",
            "affilname": "Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/125564303",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Lancaster",
            "@id": "120842452",
            "affilname": "WellSpan Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/120842452",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Yerevan",
            "@id": "114673248",
            "affilname": "Nork Clinical Hospital of Infectious Diseases",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/114673248",
            "affiliation-country": "Armenia"
        },
        {
            "affiliation-city": "Angers",
            "@id": "112625701",
            "affilname": "LUNAM University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/112625701",
            "affiliation-country": "France"
        }
    ],
    "funding": [
        "Shanghai University of Traditional Chinese Medicine, Shanghai, China",
        "St. Luke's International University"
    ]
}